Qsymia (kyoo-SIM-ee-uh) and Belviq (bel-VEEK), two new Rx drugs for weight loss

August 2012

Patients will ask about Qsymia (kyoo-SIM-ee-uh) and Belviq (bel-VEEK), two new Rx drugs for weight loss.

Qsymia is coming this fall...and Belviq early next year. But don't expect either one to be a magic bullet.

Qsymia combines low doses of phentermine and extended-release topiramate. It was previously called Qnexa.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Opioids how to safely switch opioid analgesics
HIV & AIDS Truvada (emtricitabine/tenofovir) to prevent HIV infection in adults
Supplements questions about the workout booster DMAA
Women's Health the risk of thrombosis with hormonal contraceptives
Diabetes take both a GLP-1 agonist (Byetta, etc) and DPP-4 inhibitor (Januvia, etc) for type 2 diabetes
Antithrombotics how to handle alerts for drug interactions between warfarin and many antimicrobials
Cardiology skepticism about whether fish oil supplements decrease cardiovascular risk
Lice Sklice (sklice), a new Rx lotion for head lice
Infectious Diseases prevention and treatment of diabetic foot infections
Travel Medicine how to get medications through airport screening
Obesity & Weight Loss Qsymia (kyoo-SIM-ee-uh) and Belviq (bel-VEEK), two new Rx drugs for weight loss